4th Quarter - Amendment
ALEXION PHARMACEUTICALS, INC. for ALEXION PHARMACEUTICALS, INC.
Income
—
Expenses
$285,000
Expense method
A: Lobbying Disclosure Act definitions
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report | Jan 19, 2015 | $285,000 | Replaced |
| 4th Quarter - Amendment (this page) | Feb 9, 2015 | $285,000 | Yes |
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Trade Promotion Authority TPP TTIP
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGORY KALBAUGH New | International Trade Counsel, Senate Finance Committee, Repub |
Taxation/Internal Revenue Code TAX
Corporate Tax Reform Proposals EXPIRE Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| VANESSA PROCTER | — |
Copyright/Patent/Trademark CPT
Patent Transparency and Improvements Act, S. 1720 Patent Abuse Reduction Act, S. 1013
| Lobbyist | Covered position, as disclosed |
|---|---|
| VANESSA PROCTER | — |
Health Issues HCR
21st Century Cures Initiative Biosimilars (BPCIA/ACA) Implementation
| Lobbyist | Covered position, as disclosed |
|---|---|
| VANESSA PROCTER | — |
| HEIDI L WAGNER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.